Antibody shows promise for 'bubble boy disease' treatment
March 2 (UPI) -- Antibody-based treatment instead of high-risk chemotherapy or radiation can help prepare patients with a condition known as "bubble boy disease" for a blood stem cell transplant, according to new research.Researchers at the Stanford University School of Medicine have conducted a phase 1 clinical trial on the safety and efficacy of the treatment in two humans. Dr. Judith Shizuru, professor of medicine at the school, discussed the trial Tuesday at the annual meeting of Stanford's Center for Definitive and Curative Medicine.In a university release, Shizuru said the antibody-based conditioning may be useful in combating other diseases as well, including cancer, type 1 diabetes, multiple sclerosis and lupus. For those with autoimmune diseases, the dangers of chemotherapy or rad...